Effect | Disease outcomes affected | |||
---|---|---|---|---|
Acute | Sensory stimulation | Acute eye/nose irritation | ||
Bronchospasm | ||||
Mucosal oedema | Middle ear effusion | |||
(Allergic sensitisation) | ||||
Decreased mucociliary clearance | Middle ear effusion | |||
Chronic cough and phlegm | ||||
Lower respiratory infection (leading to other outcomes) | ||||
Goblet cell hypertrophy or hypersecretion | Chronic cough and phlegm Nasal discharge | |||
Adenoidal hyperplasia | Middle ear effusion | |||
Adenotonsillectomy | ||||
Increased risk/severity of respiratory infection (mechanism uncertain) | Early LRTI Exacerbations of asthma Middle ear effusion | |||
Bronchial inflammation | Bronchial hyperreactivity | |||
Spirometric indices | ||||
Postnatal lung development | Spirometric indices | |||
Early LRTI (?esp wheezing) | ||||
?Bronchial hyperreactivity | ||||
Chronic | Prenatal growth5-150 | Spirometric indices |
LRTI = lower respiratory tract infection.
↵5-150 Due to in utero exposure to maternal smoking.